Your SlideShare is downloading. ×
Jenny Giannopoulou, Prostate cancer methylome, fged_seattle_2013
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Jenny Giannopoulou, Prostate cancer methylome, fged_seattle_2013


Published on

Characterizing the prostate cancer methylome.

Characterizing the prostate cancer methylome.

Published in: Technology, Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Characterizing the prostate cancer methylome! Jenny Giannopoulou, PhD! Institute for Computational Biomedicine!
  • 2. Institute for Computational Biomedicine
 Weill Cornell Medical College, NY!
  • 3. Elemento lab! •  Regulatory networks in normal ! and malignant cells. ChIP-seq, ! RNA-seq, computational modeling ! to investigate how genes are! regulated in cancer cells! •  Cancer genomics and precision medicine! •  Epigenomics of cancer! Organizing “EpiWorkshops” !!
  • 4. What?   Study genome-wide DNA methylation patterns in ! •  !localized PCa, ! •  !matched benign prostate tissue, as well as ! •  !CRPC (castration-resistant prostate cancer)! •  To understand how DNA methylation may contribute to PCa disease progression! •  To distinguish indolent PCa from more advanced forms! Why?  
  • 5. How?   !RRBS: Reduced Representation Bisulfite Sequencing  a high-coverage single-base resolution DNA methylation method PLoS Genet. 2012;8(6):e1002781. Epub 2012 Jun 21.! • ! Localized PCa (7) Berger MF et al. Nature. 2011 Feb 10;470(7333):214-20! • ! Matched benign prostate tissues (7)! • ! CRPC/Neuroendocrine PCa (6) Beltran H et al. Cancer Discov. 2011 Nov; 1(6):487-495.! Apply  RRBS  on  20  cases   RRBS data available at GEO: GSE41701!
  • 6. Overall increased DNA methylation in PCa, 
 consistent across cases

  • 7. Differentially methylated regions (DMRs) regions containing at least five differentially methylated CpGs! Negative correlation between DNA meth ! and gene expression! Heterogeneous methylation levels in PCa! Hyper DMRs in Promoters – Hypo in Interenic/Introns!
  • 8. EGR1 may play a role in PCa disease progression!
  • 9. DNA methylation at CGIs increases with disease severity!
  • 10. CGIs with systematic increase of methylation between benign, PCa, and CRPC!
  • 11. DNA methylation may predict disease severity!
  • 12. Dept. of Physiology and Biophysics! Institute for Computational Biology! Weill Cornell Medical College! –  Jenny Giannopoulou! –  Olivier Elemento! –  Andrea Sboner ! Dept. of Pathology and Laboratory Medicine! Weill Cornell Medical College! –  Mark Rubin! –  Pei-Chun Lin! –  Kyung Park! –  Juan Miguel Mosquera! Dept. of Medicine, Hematology Oncology Division! Weill Cornell Medical College! –  Himisha Beltran! Dept. of Urology and the LeFrak Center for Robotic Surgery! Weill Cornell Medical College! –  Ashutosh K. Tewari! Broad Institute of Harvard and MIT! Dept. of Medical Oncology, Dana Farber Cancer Institute! –  Levi Garraway! Collaborators!
  • 13. Thank you!!! @jgiannopoulou! @Elementolab!